Cargando…

Procyanidin trimer C1 reactivates latent HIV as a triple combination therapy with kansui and JQ1

Although anti-retroviral therapies have greatly extended the lives of HIV infected individuals, current treatments are unable to completely eliminate virally infected cells. A number of latency reversing agents have been proposed for use in a “shock and kill” strategy to reactivate latent HIV, thus...

Descripción completa

Detalles Bibliográficos
Autores principales: Cary, Daniele C., Peterlin, B. Matija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258234/
https://www.ncbi.nlm.nih.gov/pubmed/30475902
http://dx.doi.org/10.1371/journal.pone.0208055